Narghes Calcagno
Overview
Explore the profile of Narghes Calcagno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Straczkiewicz M, Burke K, Calcagno N, Premasiri A, Vieira F, Onnela J, et al.
J Neuroeng Rehabil
. 2024 Dec;
21(1):223.
PMID: 39707523
Background: Wearable technology offers objective and remote quantification of disease progression in neurological diseases such as amyotrophic lateral sclerosis (ALS). Large population studies are needed to determine generalization and reproducibility...
2.
Acien A, Calcagno N, Burke K, Mondesire-Crump I, Holmes A, Mruthik S, et al.
Sci Rep
. 2024 Jul;
14(1):16851.
PMID: 39039102
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative condition leading to progressive muscle weakness, atrophy, and ultimately death. Traditional ALS clinical evaluations often depend on subjective metrics, making accurate disease...
3.
Erb M, Calcagno N, Brown R, Burke K, Scheier Z, Iyer A, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Mar;
25(5-6):570-580.
PMID: 38501453
Objective: Test the feasibility, adherence rates and optimal frequency of digital, remote assessments using the ALSFRS-RSE via a customized smartphone-based app. Methods: This fully remote, longitudinal study was conducted over...
4.
Straczkiewicz M, Karas M, Johnson S, Burke K, Scheier Z, Royse T, et al.
EBioMedicine
. 2024 Mar;
101:105036.
PMID: 38432083
Background: Objective evaluation of people with amyotrophic lateral sclerosis (PALS) in free-living settings is challenging. The introduction of portable digital devices, such as wearables and smartphones, may improve quantifying disease...
5.
Tiloca C, Goldwurm S, Calcagno N, Verde F, Peverelli S, Calini D, et al.
Front Aging Neurosci
. 2022 Oct;
14:1020948.
PMID: 36247987
Background: Aggregates of TAR DNA-binding protein of 43 kDa (TDP-43) represent the pathological hallmark of most amyotrophic lateral sclerosis (ALS) and of nearly 50% of frontotemporal dementia (FTD) cases but...
6.
Giacopuzzi Grigoli E, Cinnante C, Doneddu P, Calcagno N, Lenti S, Ciammola A, et al.
Neurol Sci
. 2022 Sep;
43(12):6951-6954.
PMID: 36121546
We describe 3 cases of solitary sclerosis (SS), a rare condition characterized by a single inflammatory demyelinating lesion in the white matter of the brain or spinal cord. All patients...
7.
Verde F, Milone I, Bulgarelli I, Peverelli S, Colombrita C, Maranzano A, et al.
J Neurol
. 2022 Jul;
269(11):5691-5701.
PMID: 35781535
Background: Increased serum levels of neurofilament light chain (sNFL), a biomarker of neuroaxonal damage, have been reported in patients with Covid-19. We aimed at investigating whether sNFL is increased in...
8.
Cox L, Calcagno N, Gauthier C, Madore C, Butovsky O, Weiner H
Microbiome
. 2022 Mar;
10(1):47.
PMID: 35272713
Background: The gut microbiota can affect neurologic disease by shaping microglia, the primary immune cell in the central nervous system (CNS). While antibiotics improve models of Alzheimer's disease, Parkinson's disease,...
9.
Calcagno N, Colombo E, Maranzano A, Pasquini J, Sarmiento I, Trogu F, et al.
Neurol Sci
. 2020 May;
41(6):1339-1341.
PMID: 32394275
No abstract available.
10.
Calcagno N, Baufeld C, Madore C, Butovsky O
Immunity
. 2018 May;
48(5):842-843.
PMID: 29768169
TREM2 is known for its role in microglial phagocytosis and in neurodegenerative diseases. In this issue of Immunity, Filipello et al. (2018) show that microglial TREM2 is required for synaptic...